Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Immunotech Biopharm Ltd ( (HK:6978) ) has shared an update.
Immunotech Biopharm Ltd has announced that its board of directors will meet on March 28, 2025, to consider and approve the company’s annual results for the year ending December 31, 2024. This meeting is crucial as it will determine the financial performance of the company and could influence its market positioning and stakeholder confidence.
More about Immunotech Biopharm Ltd
Immunotech Biopharm Ltd is a biotechnology company incorporated in the Cayman Islands, focusing on the development and commercialization of innovative biopharmaceutical products. The company operates within the pharmaceutical industry, with a market focus on developing treatments and therapies for various medical conditions.
YTD Price Performance: 87.39%
Average Trading Volume: 611,035
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$2.43B
For an in-depth examination of 6978 stock, go to TipRanks’ Stock Analysis page.